|
1
|
Mignogna MD, Fedele S and Lo Russo L: The
World Cancer Report and the burden of oral cancer. Eur J Cancer
Prev. 13:139–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kudo M: Surveillance, diagnosis,
treatment, and outcome of liver cancer in Japan. Liver Cancer.
4:39–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual Report to the Nation on the Status of Cancer,
1975–2012, featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chaubal N, Joshi M, Bam A and Chaubal R:
Contrast-enhanced ultrasound of focal liver lesions. Semin
Roentgenol. 51:334–357. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Albrecht MH, Scholtz JE, Kraft J, Bauer
RW, Kaup M, Dewes P, Bucher AM, Burck I, Wagenblast J, Lehnert T,
et al: Assessment of an advanced monoenergetic reconstruction
technique in dual-energy computed tomography of head and neck
cancer. Eur Radiol. 25:2493–2501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kudo M: Locoregional therapy for
hepatocellular carcinoma. Liver Cancer. 4:163–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shady W, Petre EN, Gonen M, Erinjeri JP,
Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, et al:
Percutaneous radiofrequency ablation of colorectal cancer liver
metastases: Factors affecting outcomes - a 10-year experience at a
single center. Radiology. 278:601–611. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wildner D, Bernatik T, Greis C, Seitz K,
Neurath MF and Strobel D: CEUS in hepatocellular carcinoma and
intrahepatic cholangiocellular carcinoma in 320 patients - early or
late washout matters: A subanalysis of the DEGUM multicenter trial.
Ultraschall Med. 36:132–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fischer MA, Kartalis N, Grigoriadis A,
Loizou L, Stål P, Leidner B, Aspelin P and Brismar TB: Perfusion
computed tomography for detection of hepatocellular carcinoma in
patients with liver cirrhosis. Eur Radiol. 25:3123–3132. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mishima M, Toh U, Iwakuma N, Takenaka M,
Furukawa M and Akagi Y: Evaluation of contrast Sonazoid-enhanced
ultrasonography for the detection of hepatic metastases in breast
cancer. Breast Cancer. 23:231–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wells ML, Venkatesh SK, Chandan VS, Fidler
JL, Fletcher JG, Johnson GB, Hough DM and Roberts LR: Biphenotypic
hepatic tumors: Imaging findings and review of literature. Abdom
Imaging. 40:2293–2305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Minami Y and Kudo M: Imaging modalities
for assessment of treatment response to nonsurgical hepatocellular
carcinoma therapy: Contrast-enhanced US, CT, and MRI. Liver Cancer.
4:106–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee YJ, Lee JM, Lee JS, Lee HY, Park BH,
Kim YH, Han JK and Choi BI: Hepatocellular carcinoma: Diagnostic
performance of multidetector CT and MR imaging - a systematic
review and meta-analysis. Radiology. 275:97–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farinati F, Vanin V, Giacomin A, Pozzan C,
Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu L, Rapaccini
G, et al; Italian Liver Cancer (ITA.LI.CA) group. BCLC stage B
hepatocellular carcinoma and transcatheter arterial
chemoembolization: A 20-year survey by the Italian Liver Cancer
group. Liver Int. 35:223–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartolotta TV, Vernuccio F, Taibbi A and
Lagalla R: Contrast-enhanced ultrasound in focal liver lesions:
Where do we stand? Semin Ultrasound CT MR. 37:573–586. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fröhlich E, Muller R, Cui XW,
Schreiber-Dietrich D and Dietrich CF: Dynamic contrast-enhanced
ultrasound for quantification of tissue perfusion. J Ultrasound
Med. 34:179–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishigaki Y, Hayashi H, Tomita E, Suzuki
Y, Watanabe N, Watanabe S, Watanabe C, Takagi Y, Kato T and Naiki
T: Usefulness of contrast-enhanced ultrasonography using Sonazoid
for the assessment of therapeutic response to percutaneous
radiofrequency ablation for hepatocellular carcinoma. Hepatol Res.
45:432–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li R, Yang D, Tang CL, Cai P, Ma KS, Ding
SY, Zhang XH, Guo DY and Yan XC: Combined hepatocellular carcinoma
and cholangiocarcinoma (biphenotypic) tumors: Clinical
characteristics, imaging features of contrast-enhanced ultrasound
and computed tomography. BMC Cancer. 16:1582016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kudo M, Matsui O, Izumi N, Iijima H,
Kadoya M, Imai Y, Okusaka T, Miyayama S, Tsuchiya K, Ueshima K, et
al; Liver Cancer Study Group of Japan. JSH consensus-based clinical
practice guidelines for the management of hepatocellular carcinoma:
2014 update by the Liver Cancer Study Group of Japan. Liver Cancer.
3:458–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tacher V, Radaelli A, Lin M and Geschwind
JF: How I do it: Cone-beam CT during transarterial
chemoembolization for liver cancer. Radiology. 274:320–334. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mauri G, Cova L, De Beni S, Ierace T,
Tondolo T, Cerri A, Goldberg SN and Solbiati L: Real-time US-CT/MRI
image fusion for guidance of thermal ablation of liver tumors
undetectable with US: Results in 295 cases. Cardiovasc Intervent
Radiol. 38:143–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
